Monday, September 21, 2026

Pfizer Stock Over 2% Up So Far Today

ViaNews Editorial Team

December 1, 2020

Pfizer Stock Over 2% Up So Far Today

Shares of Pfizer jumped 2.83% to $39.40 at 14:15 EST on Tuesday, after two consecutive sessions in a row of gains. The New York Stock Exchange is rising 1.13% to $14,165.10, following yesterday's downward trend, on what up to now seems, an all-around positive trend trading session today.

Pfizer's last close was $38.31, 2.79% below its 52-week high of $40.50.

News about Pfizer today

According to today's article on Bloomberg Quint, "Pfizer, BioNTech Seek Clearance to Sell Covid Vaccine in Europe."

Pfizer, biontech seek EU clearance for covid-19 vaccine. According to today's article on Bloomberg Quint, "Pfizer Inc"

Pfizer-biontech seeks EU clearance for coronavirus vaccine. According to today's article on ForexLive, "Pfizer vaccine can be in use in the EU by the year-end if cleared Pfizer-BioNTech just announced that they have submitted an application to the EMA today to seek clearance for coronavirus vaccine use in the EU.."

Pfizer, biontech file for covid-19 vaccine approval in europe. According to today's article on The Wall Street Journal, "Pfizer and partner BioNTech said they are seeking approval from the European Union for their coronavirus vaccine.."

Pfizer's Sales

Pfizer's sales growth is a negative 9.7% for the present quarter and a decline by 9.1% for the next. The company's growth estimates for the current quarter and the next is a negative 12.7% and a negative 12.5%, respectively.

Pfizer's Revenue

Year-on-year quarterly revenue growth declined by 4.3%, now sitting on 48.65B for the twelve trailing months.

Pfizer's Stock Top and Bottom Yearly Value

Pfizer's stock is valued at $39.40 at 14:15 EST, below its 52-week high of $40.50 and way higher than its 52-week low of $26.45.

Pfizer's Moving Average

Pfizer's value is way above its 50-day moving average of $35.66 and way higher than its 200-day moving average of $34.81.

Previous days news about Pfizer

According to Bloomberg Quint on Fri Nov 27, "Malaysia Inks Pact With Pfizer to Vaccinate 6.4 Million Citizens."

Stocks making the biggest moves in the premarket: astrazeneca, disney, Pfizer, Amazon & more. According to CNBC on Fri Nov 27, "The stocks making the biggest moves in premarket trading include AstraZeneca, Disney, Pfizer, Amazon, and more.."

According to Bloomberg Quint on Sat Nov 28, "U.K"

According to Bloomberg Quint on Sat Nov 28, "U.K"

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com